Concepedia

Drug Development Classification

Drug Development Classification is a systematic framework within biopharmaceutical research that categorizes drug candidates according to their physicochemical and biological properties to inform development strategies and regulatory decision-making.

39

Publications

8.7K

Citations

151

Authors

73

Institutions

Publications per year

2017–2026

8

Parents

Publications

39

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah et al. · Pharmaceutical Research · 1995 · 5.3K citations · Full text

, , +16

Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

Lawrence X. Yu, Gordon L. Amidon, James E. Polli et al. · Pharmaceutical Research · 2002 · 565 citations · Full text

, , +11

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

Circulation · 1991 · 547 citations

, , +12

The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development

James Butler, Jennifer Dressman · Journal of Pharmaceutical Sciences · 2010 · 412 citations · Full text

, , +16

Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities

Lei Chen, Weiming Zeng, Yu‐Dong Cai et al. · PLoS ONE · 2012 · 228 citations · Full text

, , +13

1–5 of 39

Authors

151

  1. GL
    Gordon L. Amidon

    University of Michigan, United States

    3 publications · 6K citations

    3

    h-index

  2. LL
    Louis Lasagna

    Johns Hopkins University, United States

    3 publications · 96 citations

    3

    h-index

  3. KI
    Kenneth I. Kaitin

    Tufts University, United States

    3 publications · 96 citations

    3

    h-index

  4. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    3 publications · 6K citations

    3

    h-index

  5. DP
    Dale P. Conner

    United States Food and Drug Administration, United States

    2 publications · 604 citations

    2

    h-index

1–5 of 151

Institutions

73

  1. Tufts University

    Medford, United States

    4 h-index

    11 publications

    382 citations

  2. Goethe University Frankfurt

    Frankfurt am Main, Germany

    3 h-index

    6 publications

    514 citations

  3. University of Michigan

    Ann Arbor, United States

    3 h-index

    3 publications

    6K citations

  4. Uppsala University

    Uppsala, Sweden

    3 h-index

    3 publications

    5.4K citations

  5. University of Maryland, Baltimore

    Baltimore, United States

    2 h-index

    2 publications

    596 citations

  6. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    2 h-index

    3 publications

    542 citations

  7. Center for Drug Evaluation and Research

    Silver Spring, United States

    2 h-index

    23 publications

    5.1K citations

  8. Clinical Insights

    Glen Burnie, United States

    2 h-index

    2 publications

    38 citations

1–8 of 73

Venues

  1. The AAPS Journal

    AAPSJ · 4 publications · 544 citations

    4

    h-index

  2. PubMed

    Repository · 3 publications · 50 citations

    3

    h-index

  3. The Journal of Clinical Pharmacology

    3 publications · 96 citations

    3

    h-index

  4. Pharmaceutical Research

    2 publications · 5.9K citations

    2

    h-index

  5. International Journal of Pharmaceutics

    2 publications · 65 citations

    2

    h-index

1–5